216 related articles for article (PubMed ID: 15270706)
1. The effect of hyperosmotic pressure on antibody production and gene expression in the GS-NS0 cell line.
Wu MH; Dimopoulos G; Mantalaris A; Varley J
Biotechnol Appl Biochem; 2004 Aug; 40(Pt 1):41-6. PubMed ID: 15270706
[TBL] [Abstract][Full Text] [Related]
2. Development and analysis of a mathematical model for antibody-producing GS-NS0 cells under normal and hyperosmotic culture conditions.
Ho Y; Varley J; Mantalaris A
Biotechnol Prog; 2006; 22(6):1560-9. PubMed ID: 17137302
[TBL] [Abstract][Full Text] [Related]
3. Enhanced growth in NS0 cells expressing aminoglycoside phosphotransferase is associated with changes in metabolism, productivity, and apoptosis.
Veraitch FS; Al-Rubeai M
Biotechnol Bioeng; 2005 Dec; 92(5):589-99. PubMed ID: 16267848
[TBL] [Abstract][Full Text] [Related]
4. Functional proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate.
Dinnis DM; Stansfield SH; Schlatter S; Smales CM; Alete D; Birch JR; Racher AJ; Marshall CT; Nielsen LK; James DC
Biotechnol Bioeng; 2006 Aug; 94(5):830-41. PubMed ID: 16489627
[TBL] [Abstract][Full Text] [Related]
5. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors.
Spens E; Häggström L
Biotechnol Prog; 2005; 21(1):87-95. PubMed ID: 15903244
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome and proteome analysis of antibody-producing mouse myeloma NS0 cells cultivated at different cell densities in perfusion culture.
Krampe B; Swiderek H; Al-Rubeai M
Biotechnol Appl Biochem; 2008 Jul; 50(Pt 3):133-41. PubMed ID: 18302537
[TBL] [Abstract][Full Text] [Related]
7. Modulation of cell cycle for enhancement of antibody productivity in perfusion culture of NS0 cells.
Ibarra N; Watanabe S; Bi JX; Shuttleworth J; Al-Rubeai M
Biotechnol Prog; 2003; 19(1):224-8. PubMed ID: 12573029
[TBL] [Abstract][Full Text] [Related]
8. Hyperosmotic stress in murine hybridoma cells: effects on antibody transcription, translation, posttranslational processing, and the cell cycle.
Sun Z; Zhou R; Liang S; McNeeley KM; Sharfstein ST
Biotechnol Prog; 2004; 20(2):576-89. PubMed ID: 15059005
[TBL] [Abstract][Full Text] [Related]
9. Functional genome-wide analysis of antibody producing NS0 cell line cultivated at different temperatures.
Swiderek H; Al-Rubeai M
Biotechnol Bioeng; 2007 Oct; 98(3):616-30. PubMed ID: 17421047
[TBL] [Abstract][Full Text] [Related]
10. Dynamic analysis of GS-NS0 cells producing a recombinant monoclonal antibody during fed-batch culture.
Stansfield SH; Allen EE; Dinnis DM; Racher AJ; Birch JR; James DC
Biotechnol Bioeng; 2007 Jun; 97(2):410-24. PubMed ID: 17115445
[TBL] [Abstract][Full Text] [Related]
11. A genome-wide transcriptional analysis of producer and non-producer NS0 myeloma cell lines.
Khoo SH; Falciani F; Al-Rubeai M
Biotechnol Appl Biochem; 2007 Jun; 47(Pt 2):85-95. PubMed ID: 17223793
[TBL] [Abstract][Full Text] [Related]
12. Molecular definition of predictive indicators of stable protein expression in recombinant NS0 myeloma cells.
Barnes LM; Bentley CM; Dickson AJ
Biotechnol Bioeng; 2004 Jan; 85(2):115-21. PubMed ID: 14704993
[TBL] [Abstract][Full Text] [Related]
13. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
[TBL] [Abstract][Full Text] [Related]
14. Molecular portrait of high productivity in recombinant NS0 cells.
Seth G; Philp RJ; Lau A; Jiun KY; Yap M; Hu WS
Biotechnol Bioeng; 2007 Jul; 97(4):933-51. PubMed ID: 17149768
[TBL] [Abstract][Full Text] [Related]
15. Stability of recombinant protein production in the GS-NS0 expression system is unaffected by cryopreservation.
Barnes LM; Bentley CM; Dickson AJ
Biotechnol Prog; 2003; 19(1):233-7. PubMed ID: 12573031
[TBL] [Abstract][Full Text] [Related]
16. Improvement of a mammalian cell culture process by adaptive, model-based dialysis fed-batch cultivation and suppression of apoptosis.
Frahm B; Lane P; Märkl H; Pörtner R
Bioprocess Biosyst Eng; 2003 Nov; 26(1):1-10. PubMed ID: 14505167
[TBL] [Abstract][Full Text] [Related]
17. Analysis of an artificially selected GS-NS0 variant with increased resistance to apoptosis.
Browne SM; Al-Rubeai M
Biotechnol Bioeng; 2011 Apr; 108(4):880-92. PubMed ID: 21404261
[TBL] [Abstract][Full Text] [Related]
18. Transfection of NS0 myeloma fusion partner cells with HSP70 gene results in higher hybridoma yield by improving cellular resistance to apoptosis.
Lasunskaia EB; Fridlianskaia II; Darieva ZA; da Silva MS; Kanashiro MM; Margulis BA
Biotechnol Bioeng; 2003 Feb; 81(4):496-504. PubMed ID: 12491534
[TBL] [Abstract][Full Text] [Related]
19. Improved fermentation processes for NS0 cell lines expressing human antibodies and glutamine synthetase.
Dempsey J; Ruddock S; Osborne M; Ridley A; Sturt S; Field R
Biotechnol Prog; 2003; 19(1):175-8. PubMed ID: 12573022
[TBL] [Abstract][Full Text] [Related]
20. Computational approach for understanding and improving GS-NS0 antibody production under hyperosmotic conditions.
Ho Y; Kiparissides A; Pistikopoulos EN; Mantalaris A
J Biosci Bioeng; 2012 Jan; 113(1):88-98. PubMed ID: 22018734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
